The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study-Reference-Cited by-同舟云学术

The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study

Published:2016-09 Issue:9 Volume:26 Page:1293-1299
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Onoda Naoyoshi¹²,Sugino Kiminori¹³,Higashiyama Takuya¹⁴,Kammori Makoto¹⁵,Toda Kazuhisa⁶,Ito Ken-ichi¹⁷,Yoshida Akira¹⁸,Suganuma Nobuyasu⁹,Nakashima Noriaki¹⁰,Suzuki Shinichi¹¹¹,Tsukahara Kiyoaki¹²,Noguchi Hitoshi¹³,Koizumi Masanori¹⁴,Nemoto Toshimitsu¹⁵,Hara Hisato¹¹⁶,Miyauchi Akira¹⁴,Sugitani Iwao¹⁶¹⁷

Affiliation:

1. Prospective Clinical Study Committee of Anaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo, Japan.

2. Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.

3. Department of Surgery, Ito Hospital, Tokyo, Japan.

4. Department of Surgery, Kuma Hospital, Kobe, Japan.

5. Department of Surgery, Kanaji Thyroid Hospital, Tokyo, Japan.

6. Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan.

7. Department of Surgery II, Shinshu University, Matsumoto, Japan.

8. Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.

9. Department of Surgery, Yokohama City University, Kanagawa, Japan.

10. Department of Breast and Endocrine Surgery, Tohoku University, Sendai, Japan.

11. Department of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima, Japan.

12. Department of Otolaryngology, Tokyo Medical University, Tokyo, Japan.

13. Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan.

14. Department of Surgery, Mito Medical Center, Mito, Japan.

15. Department of Otorhinolaryngology, Japanese Red Cross Narita Hospital, Chiba, Japan.

16. Department of Breast and Endocrine Surgery, Tsukuba University, Tsukuba, Japan.

17. Department of Endocrine Surgery, Nippon Medical School, Tokyo, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0072

Reference18 articles.

1. Approach to the Patient with Anaplastic Thyroid Carcinoma

2. Marginal treatment benefit in anaplastic thyroid cancer

3. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

4. Anaplastic thyroid carcinoma: A 50-year experience at a single institution

5. Prognostic Factors and Treatment Outcomes of 100 Cases of Anaplastic Thyroid Carcinoma

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies;Frontiers in Endocrinology;2024-06-26

2. Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies;Frontiers in Endocrinology;2024-02-26

3. Exploration of systematic treatment strategies for anaplastic thyroid carcinoma: A single-institutional retrospective study;2023-10-10

4. Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer;Oncology Letters;2023-08-08

5. Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report;Surgical Case Reports;2023-03-15